Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IGHE
Clinical data
ATC code none
CAS Number 1228538-47-3
ChemSpider none
Chemical and physical data
Formula C6492H10046N1728O2023S44
Molar mass 146.1 kg/mol

Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma.[1] It binds to IGHE.[2]

This drug was developed by Genentech.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Quilizumab, American Medical Association.
  2. World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 106" (PDF). WHO Drug Information. 25 (4).
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.